Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Agreement and Plan of Merger

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Agreement and Plan of Merger

Entities:

Eon Labs, Inc.

Date:

2005

Size:

96KB total

Price:

$35

ID:

#1178302

 

 

► Plans ► Agreements ► Agreements & Plans of Merger
► Biotech & Drugs ► Pharmaceutical Preparations

 

 

Start of Preview


 

 

AGREEMENT AND PLAN OF MERGER

 

by and among

 

NOVARTIS CORPORATION

 

 

ZODNAS ACQUISITION CORP.

 

 

an indirect, wholly owned subsidiary of Novartis Corporation

 

 

EON LABS, INC.

 

 

and for purposes of Section 10.12 only, NOVARTIS AG

 

 

Dated as of February 20, 2005

 

 



 

TABLE OF CONTENTS

 

AGREEMENT AND PLAN OF MERGER

 

 

 

 

ARTICLE I The Offer

 

1.1

The Offer

 

1.2

Company Actions

 

1.3

Directors

 

 

 

 

ARTICLE II The Merger

 

2.1

The Merger

 

2.2

Effective Time

 

2.3

Certificate of Incorporation

 

2.4

By-Laws

 

2.5

Directors

 

2.6

Officers

 

 

 

 

ARTICLE III Effect of the Merger on Capital Stock; Exchange of Certificates

 

3.1

Effect on Capital Stock

 

3.2

Exchange of Share Certificates

 

3.3

Dissenters Rights

 

3.4

Stockholders Meeting

 

3.5

Merger Without Meeting of Stockholders

 

 

 

 

ARTICLE IV The Closing

 

4.1

Closing

 

 

 

 

ARTICLE V Representations and Warranties

 

5.1

Representations and Warranties of the Company

 

5.2

Representations and Warranties of Novartis and Merger Sub

 

 

 

 

ARTICLE VI Conduct of Business Pending the Merger

 

6.1

Covenants of the Company

 

 

 

 

ARTICLE VII Additional Agreements

 

7.1

Access

 

7.2

No Solicitation

 

7.3

Other Actions; Notification

 

7.4

Publicity

 

7.5

Expenses

 

7.6

Anti-Takeover Statute

 

7.7

Novartis Vote

 

7.8

Section 16 Matters

 

7.9

Indemnification; Directors and Officers Insurance

 

 

 

 

ARTICLE VIII Conditions

 

 

i



 

8.1

Conditions to Each Partys Obligation to Effect the Merger

 

 

 

 

ARTICLE IX Termination

 

9.1

Termination by Mutual Consent

 

9.2

Termination Upon Termination of the Santo Agreement

 

9.3

Termination Upon Expiration of Offer Without Requisite Tender Amount

 

9.4

Effect of Termination and Abandonment

 

 

 

 

ARTICLE X Miscellaneous and General

 

10.1

Survival

 

10.2

Modification or Amendment

 

10.3

Waiver of Conditions

 

10.4

Counterparts

 

10.5

Governing Law and Venue

 

10.6

Notices

 

10.7

Entire Agreement; No Other Representations

 

10.8

No Third-Party Beneficiaries

 

10.9

Severability

 

10.10

Interpretation

 

10.11

Assignment

 

10.12

Parent Guarantee

 

 

ii



 

INDEX OF DEFINED TERMS

 

Defined Term

 

Section

 

 

 

Acceptance Date

 

1.1(b)

Affiliate

 

5.1(a)

Agreement

 

Preamble

Anti-Takeover Statute

 

7.6

Business Day

 

1.1(a)

By-Laws

 

2.4

Certificate

 

3.1(c)

Certificate of Incorporation

 

2.3

Certificate of Merger

 

2.2

Closing

 

4.1

Closing Date

 

4.1

Company

 

Preamble

Company Common Stock

 

Recitals

Company Disclosure Schedule

 

5.1

Company Material Adverse Effect

 

5.1(a)

Company Option

 

3.1(d)

Company Outstanding Shares

 

3.2(a)

Company Report

 

5.1(e)(i)

D&O Insurance

 

7.10(ii)

DGCL

 

1.2(a)

Dissenting Shares

 

3.3(a)

Effective Time

 

2.2

Exchange Act

 

1.1(a)

Exchange Fund

 

3.2(a)

Expiration Date

 

1.1(b)

Governmental Entity

 

1.1(a)

Indemnified Person

 

7.9(b)

Law

 

1.1(b)

Maximum Annual Premium

 

7.9(b)

Merger

 

Recitals

Merger Consideration

 

3.1(c)

Merger Sub

 

Preamble

Merrill Lynch

 

1.2(a)

Novartis

 

Preamble

Novartis Disclosure Schedule

 

5.2

Offer

 

Recitals

Offer Documents

 

1.1(a)

Offer Price

 

Recitals

Option Cash Payment

 

3.1(d)

Organizational Documents

 

5.1(a)

 

iii



 

Defined Term

 

Section

 

 

 

Paying Agent

 

3.2(a)

Person

 

3.2(b)

Preferred Stock

 

5.1(b)

Proxy Statement

 

3.4(a)(ii)

Public Shares

 

Recitals

Representatives

 

7.1

Requisite Tender Amount

 

8.1(a)

Santo

 

Recitals

Santo Agreement

 

Recitals

Santo Purchaser

 

Recitals

Santo Shares

 

Recitals

Schedule 14D-9

 

1.2(a)

SEC

 

1.1(a)